1Assistant Professor, Department of Lab Sciences, Boroujerd Branch, Islamic Azad University, Boroujerd, Iran
2Department of Microbiology, Boroujerd Branch, Islamic Azad University, Boroujerd, Iran
Background & Aims: Organisms producing TEM-β-lactamase are emerging around the world as a source of resistance to β-lactam antibiotics such as three generation cephalosporins. In this study, we used a polymerase chain reaction (PCR) to identify genes TEM for Extended-spectrum β-lactamase (ESBLs) producing clinical isolates of Klebsiella pneumonia from hospitals of Boroujerd/ Iran.
Method: A total of 100 K. pneumoniae isolates were collected from different hospitals in Boroujerd. Phenotypic screening and confirmatory tests for ESBL detection were performed according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Minimum inhibitory concentration (MIC) of azteronam, amikacin, ciprofloxacin and meropenem were determined by micro broth dilution method. All of the ESBL-producing isolates were examined for the presence of TEMgene by PCR method.
Results: Primary phenotypic tests revealed that 41% (n=31) of K. pneumonia isolates produced ESBLs. In confirmatory tests using clavulanic acid, ESBL production was confirmed in 100% of isolates with a primary positive test. Among the ESBL producing K. pneumoniae, 31 isolates were positive for TEM gene. The study showed excellent susceptibility among the strains to meropenem and amikacin. Low susceptibility to ciprofloxacin and the lowest susceptibility to azteronam were observed.
Conclusion: ESBLs producing isolates can be combined with resistance to other classes of antibiotics such as aminoglycosides. Also, meropenem can be a good treatment options to control infections caused by ESBLs producing organisms.
Koneman EW, Allen S, Janda WM (editors). Color atlas and text book of diagnostic microbiology. 5th ed. Philadelphia, Lippincott 1997; PP 171-241.
Shahcheraghi NV, shoraj F. Evaluation existance of blaTEM and blashv Beta-lactamase genes in resistance antibiotic Escherichia coli strains isolated from clinical samples obtained from Tehran Hospitals. J Iran med microbiol 2007; 1(4): 21-7 [In Persian].
Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11(6): 315-7.
Nathisuwan S, Burgess DS, Lewis JS. Extended-spectrum b-lactamases: epidemiology, detection, and treatment. Pharmacotherapy 2001; 21: 920-8.
Medeiros AA. Beta lactamases. Br Med Bull 1984; 40(1): 18-27.
Mlynarczyk G, Mlynarczyk A, Bilewska A, Dukaczewska A, Holawski C, Kicman A, et al. High effectiveness of the method with cefpirome in detection of extended-spectrum beta-lactamases in different species of gram-negative bacilli. Med Dosw Mikrobiol 2006; 58(1): 59-65.
Haghi F, Zeighami H, Keramati N, Hemmati F, Hajiahmadi F. Frequency of TEM extended spectrum beta lactamase producing Escherichia coli in clinical specimens by phenotypic and molecular methods in Zanjan. Zanjan Univ Med SciJ 2013; 21(85):55-63.
Henshke-Bar-Meir R, Yinnon AM, Rudensky B, Attias D, Schlesinger Y, Raveh D. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae. Infection 2006; 34(2): 66-74.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial SusceptibilityTesting. 16th Informational Supplement (M100-S16), CLSI, Wayne, PA 2006; 26(3): 15-100.
Khorshidi A, Rohani M, Moniri R. The prevalence and molecular characterization of extended-spectrum β-lactamases-producing Klebsiella pneumoniae isolates recovered from Kashan hospital university, Iran. Jundishapur J Microbiol 2011; 4)4(. 289-94 [In Persian].
Sadeghi MR, Nahaei MR, Soltan Dalal MM. Extended spectrum beta-lactamase resistance in clinical isolates of K. pneumoniae and E. coli in in-patient and out-patient groups. Med J Tabriz Univ Med Sci 2008; 30(2): 79-86.
Izadi N, Naderi Nasab M , Harifi Mood E, Meshkat Z. Prevalence of TEM and SHV Genes in Clinical Isolates of Klebsiella Pneumonia From Mashhad, North- East Iran. Iran J Pathol 2014; 9 (3): 199.
Yousefi Mashouf R, Alijani P, Saidijam M, Alikhani M.Y, Rashidi H. Study of Antibiotic Resistance Pattern and Phenotypic Detection of ESBLs in Klebsiella Pneumoniae Strains Isolated from Clinical Samples and Determination of Minimum Inhibitory Concentrations of Imipenem and Ceftazidim Antibiotics. Sci J Hamadan Univ Med Sci 2014; 20)4(: 295-302.
Pitout JD. Multiresistant Enterobacteriaceae: New threat of an old problem. Expert Rev Anti Infect Ther 2008; 6(5):657-69.
Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum b-lactamases producing Enterobacteriaceae in Europe. Clin Microbiol Infec 2008; 14(1): 144-53.
Khaneja M, Naprawa J, Kumar A, Piecuch S. Successful treatment of late-onset infection due to resistant Klebsiella pneumoniae in an extremely low birth weight infant using ciprofloxacin. J Perinatol 1999; 19(4): 311-4.
Soltan Dallal MM, Sharifi Yazdi MK, Avadisian S, Agha Mirazaei H, Sabaghi A. Efficacy of Ciprofloxacin, Ceftizoxims and Carbenicillin on Klebsiella species isolated from hospital specimens. Gorgan Uni Med Sci J 2013; 15 (3): 77-83.
Panahi Y, Mojtahedzadeh M, Safarnejad S, Beiraghdar F. Patterns of antibiotic resistance in strains isolated from urinary tract infections ICU. Kowsar Med J 2008; 13(3): 229-38 [In Persian].
Tawfik AF, Alswailem AM, Shibl AM, Al-Agamy MH. Prevalence and Genetic Char cteristics of TEM, SHV, and CTX-M in Clinical Klebsiella pneumoniae Isolates from Saudi Arabia. Microb Drug Resist 2011; 17(3): 383-8.
Feng-yee-chang, Siu LK, Fung CP, Huang M.H, Ho M. Diversity of SHV and TEM -Lactamases in Klebsiella pneumoniae: Gene Evolution in Northern Taiwan and Two Novel B-Lactamases, SHV-25 and SHV-26. Antimicrob Agents Chemother. 2016; 60(8): 2407-13.
Burcu Bali E, Açik L, Sultan N. Phenotypic and molecular characterization of SHV, TEM, CTX-M and extended-spectrum–lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res 2010; 4 (8): 650-4.
Goudarzi G, Baharvand Ahmadi A. The occurrence of TEM gene among the extended-spectrum β-lactamases (ESBLs) producing uropathogenic Escherichia coli strains, isolated from Khorramabad city in 2013. Pajouhandeh J 2015; 20(1):33-7.
Zadegan HH, Ramazanzadeh R, Hasany A. Cross-sectional study of extended spectrum beta-lactamase producing gram-negative bacilli from clinical cases in Khorramabad, Iran. Iranian Journal of Microbiology 2009; 1(3): 16-9.
Raei F, Eftekhar F, Feizabadi M. M. Correlation of extended-spectrum β-lactamase phenotype with blaSHV, blaTEM and blaCTX-M gene carriage in urinary isolates of Klebsiella pneumonia in Tehran. 2014; 27(1): 35-44
Nasehi L, Shahcheraghi F, Nikbin V, Nematzadeh S. PER, CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of Klebsiella pneumoniae Isolated from Tehran, Iran. Iran J Basic Med Sci 2010; 13(3): 111-8.
Behroozi A, Rahbar M, Yousefi Vand J. Frequency of extended spectrum beta-lactamases (ESBLs) producing E. coli and K. pneumonia isolated from urine in an Iranian 1000-bed tertiary care hospital. Afr J Microbiol Res 2010; 4(9): 881-4.
Riyahi Zaniani F, Meshkat Z, Nasab MN, Khaje-Karamadini M, Ghazvini K, Rezaee A, et al. The Prevalence of TEM and SHV Genes among Extended-Spectrum Beta-Lactamases Producing Escherichia Coli and Klebsiella Pneumoniae.Iran J Basic Med Sci 2012; 15(1): 654-60.
Feizabadi MM, Mahamadi-Yeganeh S, Mirsalehian A, Mirafshar SM, Mahboobi M, Nili F, et al. Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. J Infect Dev Ctries. 2010; 4(10): 609-15.
Talukdar PK, Rahman M, Rahman M, Nabi A, Islam Z, Hoque MM, et al. Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh. Plos one 2013; 8(4): e61090.